Your browser doesn't support javascript.
loading
Association of aortic dissection and lipoprotein (a): a meta-analysis.
Motawea, Karam R; Elhalag, Rowan H; Rouzan, Samah S; Talat, Nesreen E; Reyad, Sarraa M; Chébl, Pensée; Mohamed, Mai S; Shah, Jaffer.
Afiliación
  • Motawea KR; Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Elhalag RH; Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Rouzan SS; Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Talat NE; Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Reyad SM; Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Chébl P; Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Mohamed MS; Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Shah J; Weill Cornell Medicine, New York, NY.
Ann Med Surg (Lond) ; 85(6): 2896-2905, 2023 Jun.
Article en En | MEDLINE | ID: mdl-37363556
ABSTRACT
Some studies reported a positive relation between aortic dissection (AD) and increased lipoprotein (a) (LP(a)), while other studies reported no association, so the authors aimed to do a meta-analysis to establish the relation between AD and high levels of LP(a).

Methods:

PubMed, Scopus, Web of Science, SAGE, EMBASE, Science Direct, and Cochrane Library were searched. The inclusion criteria were any randomized control trials or observational studies that measured the levels of LP(a) in AD patients and healthy controls. The authors excluded case reports, case series, noncontrolled studies, reviews, editorials, and animal studies.

Results:

After a search of the literature, four studies were included in the meta-analysis with 678 patients included in the analysis. The pooled analysis showed a statistically significant association between the AD group and increased levels of LP(a), decreased levels of TG, low-density lipoprotein cholesterol, and TC compared with the control group (MD=11.71, 95% CI=4.11-19.32, P-value=0.003), (MD=-0,32, 95% CI=-0.48 to -0.16, P-value<0.0001 ), (MD=-0,21, 95% CI=-0.42 to -0.1, P-value=0.04), (MD=-0,58, 95% CI=-0.62 to -0.54, P-value<0.00001), respectively.

Conclusion:

Our study showed that AD is significantly associated with increased levels of LP(a). The significant increase in LP(a) in AD was associated with decreased levels of TG, low-density lipoprotein cholesterol, and TC. Future clinical trials testing Lp (a) targeting medications could be useful in the primary, or secondary prevention of AD in high risk patients.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Ann Med Surg (Lond) Año: 2023 Tipo del documento: Article País de afiliación: Egipto

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Ann Med Surg (Lond) Año: 2023 Tipo del documento: Article País de afiliación: Egipto